Orthometrix (OMRX) Stock Analysis & Winston Score
Orthometrix is a small medical device company that sells equipment used to treat bone and soft tissue conditions without surgery. Its main product is the Hivamat, a device that uses electrical fields to reduce pain and swelling — used by physical therapists, sports medicine clinics, and rehabilitation centers. The company distributes medical devices primarily in the United States. Orthometrix makes money by selling and leasing its devices directly to healthcare providers, and it earns additional revenue from related accessories and supplies. It is a very small company with a market cap under $10 million, but its high gross margins and strong return on invested capital suggest it holds a niche position in its narrow product category. The key risk is its tiny size — it has limited resources to expand its sales force, fund new product development, or compete if a larger medical device company targets the same market.
Winston Score: 32/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (11/30)
- Growth: Weak (1/20)
- Cash Flow: Weak (0/10)
- Stability: Weak (2/10)
- Valuation: Good (6/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.00
Market Cap: $0M
Sector: Healthcare
Industry: Medical - Specialties

